GoodRx Holdings, Inc. (NASDAQ: GDRX) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $1.2B. The Maz Rating grades it against the other companies in its sector.
GoodRx Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.47, GoodRx Holdings, Inc. trades at 66.6x trailing earnings, 1.5x sales and 1.8x book value, with an EV/EBITDA of 8.3. Over the last twelve months it generated about $777M of revenue and $18M of net income. It runs a gross margin of 88.1%, an operating margin of 10.2% and a net margin of 2.1%. It shows return on equity of 2.6%, return on invested capital of 2.6% and a free cash flow yield of 12.3%. On the balance sheet: a debt-to-equity ratio of 0.83 and a current ratio of 1.38. Over the past 52 weeks the share price ranged from $1.77 to $3.89, with a beta of 1.67.
GoodRx Holdings, Inc. does not currently pay a dividend.
24 Wall Street analyst ratings cover the stock: 9 Buy, 13 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of June 2026, GoodRx Holdings, Inc. (GDRX) passes 1 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI, and fails AAOIFI, S&P Global, Dow Jones and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 41.4% / 30% · (Cash+Inv) / Mkt Cap (36m) 25.2% / 30% · Interest income / Revenue 0.51% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 41.4% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 25.2% / 33% · Receivables / Mkt Cap (36m) 107.0% / 49% · Interest income / Revenue 0.51% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 41.4% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 25.2% / 33.33% · Receivables / Mkt Cap (24m) 107.0% / 33.33% · Interest income / Revenue 0.51% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 27.5% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 15.0% / 33.33% · Receivables / Avg Assets (4Q) 27.8% / 33.33% · Interest income / Revenue 0.51% / 5% | Pass |
| FTSE | Debt / Total Assets 20.8% / 33.33% · (Cash+ST Inv) / Total Assets 12.6% / 33.33% · (Cash+Recv) / Total Assets 66.3% / 33.33% · Interest income / Revenue 0.51% / 5% | Fail |
It depends on the standard you follow. As of June 2026, GoodRx Holdings, Inc. (GDRX) passes 1 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI, and fails AAOIFI, S&P Global, Dow Jones and FTSE.
No. GoodRx Holdings, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m).
About 0.51% of each dividend: GoodRx Holdings, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated June 30, 2026 (Q2 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.